Skip to main content

US sends 2 million doses of unproven virus drug to Brazil

NewsColony
US sends 2 million doses of unproven virus drug to Brazil

Donald Trump wearing a suit and tie standing in front of a flag: US President Donald Trump speaks with Brazilian President Jair Bolsonaro during a dinner at Mar-a-Lago in Palm Beach, Florida, US in March © Jim WATSON US President Donald Trump speaks with Brazilian President Jair Bolsonaro during a dinner at Mar-a-Lago in Palm Beach, Florida, US in March

The United States has delivered two million doses of the antimalarial medicine hydroxychloroquine (HCQ) to Brazil to fight COVID-19, the White House said Sunday, though the drug has not been proven effective against the coronavirus.

“HCQ will be used as a prophylactic to help defend Brazil’s nurses, doctors, and healthcare professionals against the virus. It will also be used as a therapeutic to treat Brazilians who become infected,” a statement said.

It said the US would soon also send 1,000 ventilators to Brazil, the epicenter of South America’s outbreak with nearly 500,000 confirmed cases.

“We are also announcing a joint United States-Brazilian research effort that will include randomized controlled clinical trials,” it added.

President Donald Trump is an outspoken fan of HCQ, which has been used to treat malaria for decades as well as the autoimmune disorders lupus and rheumatoid arthritis.

He has previously said he is taking it himself in the hope of avoiding infection with the virus.

There is currently no evidence from a randomized controlled trial (RCT) — considered the gold standard of clinical investigation — for HCQ’s use either to treat or prevent COVID-19.

There are also fears that it may in fact worsen coronavirus patient’s outcomes.

A paper published in The Lancet last week concluded that treating people who have Covid-19 with hydroxychloroquine and a related compound chloroquine did not help them and might have increased the risk of abnormal heart rhythms and death.

The study was not an RCT, and more than 100 clinicians and scientists have since questioned the authenticity of a hospital database it relied on to reach its conclusions.

HCQ has been granted an emergency use authorization for COVID-19 in the US for patients under close heart monitoring.

The Food and Drug Administration has asked doctors not to prescribe it widely or outside of several clinical trials that are underway.

Like Trump, Brazilian President Jair Bolsonaro is an advocate of HCQ and has sacked two health ministers who clashed with him over his desire to expand its use. 

Despite losing nearly 30,000 people to the virus, Bolsonaro has railed against the “tyranny” of lockdowns and called for the country’s soccer season to resume.

The US has lost more than 106,000 people to the virus, by far the country with the highest number of deaths. 

The World Health Organization said last week it was temporarily halting testing of the HCQ for COVID-19 over growing safety concerns, including those raised in The Lancet paper.

ia/bgs

Source: MSN

The post US sends 2 million doses of unproven virus drug to Brazil appeared first on NewsColony.
NewsColony



source https://newscolony.com/us-sends-2-million-doses-of-unproven-virus-drug-to-brazil/

Comments

Popular posts from this blog

What you should do if you have coronavirus

NewsColony What you should do if you have coronavirus Click to expand Replay Video UP NEXT Watch a COVID-19 Lab Test Watch a COVID-19 Lab Test Redding Record Searchlight Redding’s first cannabis store, Synergy, opens for business Redding’s first cannabis store, Synergy, opens for business Redding Record Searchlight Five tips to be a rock painter Five tips to be a rock painter Redding Record Searchlight SETTINGS OFF HD HQ SD LO Skip Ad UP NEXT You wake up with a dry cough or headache. It could be the common cold or allergies, or it could be the coronavirus.  So, what should you do next?  The Centers for Disease Control and Prevention and other public health experts recommend taking the following steps if you’re feeling sick and think you may have COVID-19.  Start the day smarter. Get all the news you need in your inbox each morning. Do an inventory of symptoms:  Dry cough is one. Are you also short

Coronavirus Live Updates: Online Retailers Plan Campaign to Rescue Postal Service

NewsColony Coronavirus Live Updates: Online Retailers Plan Campaign to Rescue Postal Service Here’s what you need to know: Image A United States Postal Service employee making deliveries in the Bronx last month. Credit… Desiree Rios for The New York Times Online retailers, including Amazon, want Congress to save the Postal Service. A coalition of online retailers backed by Amazon plans to start on Wednesday a seven-figure advertising blitz opposing President Trump’s demand that the beleaguered United States Postal Service ratchet up its package delivery rates to avoid bankruptcy during the coronavirus crisis, its top lobbyist said. The ads will begin running nationally Wednesday night on “Hannity,” one of Mr. Trump’s favorite programs on Fox News, and on Rush Limbaugh’s radio show on Thursday. They do not mention the president but label his proposal to raise delivery prices “a massive package tax” on small businesses and Americans who rely on the mail for pre

China’s military is world’s first to use experimental virus vaccine

NewsColony China’s military is world’s first to use experimental virus vaccine © AFP An experimental coronavirus vaccine has been approved for use by the Chinese military – a first for the armed forces of any country. Photo: AFP China has approved military use of an experimental coronavirus vaccine developed by the People’s Liberation Army and a Chinese pharmaceutical company, in a first for the armed forces of any country. The vaccine, identified as Ad5-nCoV, was jointly developed by a team at the Academy of Military Medical Sciences, led by Major General Chen Wei, and Tianjin-based company CanSino Biologics . It is the first time that a vaccine candidate for Covid-19, the disease caused by the coronavirus, has been authorised for use for the military of any nation. CanSino said on Monday that the candidate had been through two phases of clinical trials, which indicated it was safe and there was “relatively high” immune response to the antigen. The candidate is yet to start